Loading stock data...

Kwality Pharmaceuticals Limited

BSE: KPL

BSE
1,026.45 27.05 (2.71%)

Prev Close

999.4

Open Price

1002

Volume

16,571

Today Low / High

1002 / 1049

52 WK Low / High

596.05 / 1235

Range

975 - 1,078

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 1026.45, reflecting a change of 27.05 (2.70662%). The expected target range on the BSE is 975 - 1,078. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

19 Dec 1,002.00 2.44%
18 Dec 937.00 6.66%
17 Dec 922.00 3.34%
16 Dec 944.15 -1.42%
15 Dec 976.00 -3.26%
12 Dec 940.00 2.70%
11 Dec 910.00 4.86%
10 Dec 880.00 1.85%
09 Dec 871.35 3.19%
08 Dec 909.00 -4.14%
05 Dec 897.95 -0.25%
04 Dec 910.20 -2.44%
03 Dec 920.05 -1.57%
02 Dec 915.05 0.73%
01 Dec 929.00 -0.60%
28 Nov 923.95 0.81%
27 Nov 900.00 2.52%
26 Nov 908.95 -0.08%
25 Nov 900.00 -0.27%
24 Nov 944.10 -4.87%

Kwality Pharmaceuticals Limited Graph

Kwality Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Kwality Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,026.45, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 1,026.45 1,036.71 933.04 - 1,140.39
1,046.98 837.58 - 1,256.37
1,057.24 740.07 - 1,374.42
Bearish Scenario 1,026.45 1,016.19 914.57 - 1,117.80
1,005.92 804.74 - 1,207.11
995.66 696.96 - 1,294.35

Overview of Kwality Pharmaceuticals Limited

ISIN

INE552U01010

Industry

Medical - Pharmaceuticals

Vol.Avg

11,329

Market Cap

10,650,648,437

Last Dividend

0

Official Website

Visit Website

IPO Date

2016-07-18

DCF Diff

490.83

DCF

536

Financial Ratios Every Investor Needs

Stock Dividend of KPL

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2017-01-05 January 05, 17 0.3 0.6

Stock Rating Details for KPL

Metric Value Recommendation
Overall Rating B+ Neutral
DCF Score 4 Buy
ROE Score 4 Buy
ROA Score 5 Strong Buy
Debt-to-Equity (DE) Score 2 Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 2 Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 370.20 Cr 182.49 Cr 187.71 Cr 0.5071 0.00 Cr 43.78 Cr 143.93 Cr 39.85 Cr 38.36 82.31 Cr 0.1076
2024-03-31 307.17 Cr 163.47 Cr 143.70 Cr 0.4678 0.00 Cr 4.81 Cr 46.79 Cr 23.80 Cr 22.93 61.04 Cr 0.0775
2023-03-31 251.03 Cr 119.54 Cr 131.49 Cr 0.5238 5.04 Cr 6.93 Cr 48.08 Cr 19.37 Cr 18.67 47.14 Cr 0.0772
2022-03-31 456.19 Cr 210.19 Cr 245.99 Cr 0.5392 5.02 Cr 3.51 Cr 162.91 Cr 119.99 Cr 115.64 175.17 Cr 0.2630
2021-03-31 262.01 Cr 171.33 Cr 90.68 Cr 0.3461 3.17 Cr 2.78 Cr 23.96 Cr 15.15 Cr 14.60 30.44 Cr 0.0578

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 12.02 Cr 447.27 Cr 184.88 Cr 264.0483 Cr 112.45 Cr 97.69 Cr 83.47 Cr 143.98 Cr 4.97 Cr 0.00 Cr 0.00 Cr 169.5050 Cr
2024-03-31 2.26 Cr 394.21 Cr 171.63 Cr 224.2114 Cr 98.12 Cr 95.86 Cr 78.39 Cr 150.43 Cr 18.48 Cr 0.00 Cr 0.00 Cr 151.8501 Cr
2023-03-31 3.07 Cr 353.63 Cr 154.56 Cr 200.5165 Cr 90.26 Cr 87.19 Cr 86.31 Cr 134.79 Cr 18.53 Cr 0.00 Cr 0.93 Cr 125.9457 Cr
2022-03-31 9.13 Cr 340.59 Cr 160.80 Cr 181.1441 Cr 54.01 Cr 44.88 Cr 53.36 Cr 103.88 Cr 71.25 Cr 9.18 Cr -3.03 Cr 139.4861 Cr
2021-03-31 5.81 Cr 166.26 Cr 106.41 Cr 61.1526 Cr 41.23 Cr 35.42 Cr 17.36 Cr 59.42 Cr 20.93 Cr 0.00 Cr -4.38 Cr 78.2905 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 52.7178 Cr -28.5152 Cr -14.4404 Cr 29.4251 Cr 9.7623 Cr 12.0202 Cr -23.2927 Cr 39.8451 Cr -4.5624 Cr 0.0000 Cr -5.0783 Cr
2024-03-31 42.9828 Cr -26.3966 Cr -17.3978 Cr 13.1417 Cr -0.8117 Cr 2.2579 Cr -30.6379 Cr 31.0989 Cr -7.2025 Cr 0.0000 Cr 2.7349 Cr
2023-03-31 41.3817 Cr -48.4408 Cr 0.9941 Cr -6.2915 Cr -6.0650 Cr 3.0696 Cr -47.6732 Cr 25.5724 Cr 0.9941 Cr 0.0000 Cr -32.9544 Cr
2022-03-31 60.5969 Cr -62.9276 Cr 5.6567 Cr 5.4445 Cr 3.3261 Cr 9.1346 Cr -55.1524 Cr 161.5668 Cr 8.5740 Cr 0.0000 Cr -35.9957 Cr
2021-03-31 26.7054 Cr -23.2026 Cr 0.7673 Cr 3.3059 Cr 4.2701 Cr 5.8085 Cr -23.3995 Cr 21.2716 Cr 3.4389 Cr 0.0000 Cr 5.0523 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-09-30 111.05 Cr 72.90 Cr 38.15 Cr 0.3436 20.40 Cr 14.12 Cr 13.60 26.25 Cr 0.1271
2025-06-30 111.48 Cr 58.03 Cr 53.45 Cr 0.4794 19.41 Cr 11.93 Cr 11.49 24.55 Cr 0.1070
2025-03-31 115.68 Cr 60.79 Cr 54.89 Cr 0.4745 42.20 Cr 14.49 Cr 13.95 26.14 Cr 0.1253
2024-12-31 84.41 Cr 38.73 Cr 45.68 Cr 0.5412 12.94 Cr 8.53 Cr 8.22 18.15 Cr 0.1011
2024-09-30 90.03 Cr 58.88 Cr 31.16 Cr 0.3460 15.04 Cr 8.47 Cr 8.16 19.88 Cr 0.0941

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 31.24 Cr 2.81 Cr 34.05 Cr 163.49 Cr 83.84 Cr 320.06 Cr 142.13 Cr 477.65 Cr 189.20 Cr
2025-06-30 0.00 Cr 0.00 Cr 14.76 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -262.40 Cr
2025-03-31 12.02 Cr 2.74 Cr 14.76 Cr 154.31 Cr 83.47 Cr 283.78 Cr 143.98 Cr 447.27 Cr 184.88 Cr
2024-12-31 0.00 Cr 0.00 Cr 7.76 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -239.38 Cr
2024-09-30 3.10 Cr 4.67 Cr 7.76 Cr 113.26 Cr 83.14 Cr 242.94 Cr 137.73 Cr 393.50 Cr 154.11 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 11.93 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 14.49 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 8.53 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 8.47 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 8.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2017-10-11 October 11, 17 2:1

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹820.55 ₹98,275,382,953.00 ₹102,302.00

Key Executives

Chief Financial Officer & Whole Time Director
Aditya Arora

Gender: male

Year Born: 1994

Whole Time Director
Ajay Kumar Arora

Gender: male

Year Born: 1968

Whole Time Director
Anju Arora

Gender: female

Year Born: 1962

Whole Time Director
Geeta Arora

Gender: female

Year Born: 1970

MD & Director
Ramesh Arora

Gender: male

Year Born: 1954

Chief Domestic Sales Officer
Shankar Dayal

Gender: male

Year Born: 1985

Company Secretary & Compliance Officer
Gurpreet Kaur

Gender: female

Year Born:

FAQs about Kwality Pharmaceuticals Limited

Who is the CEO of the company?

The CEO is Ramesh Arora.

What is the current market price of the stock?

The current price is ₹1,026.45.

What is the 52-week price range?

The range is ₹596.05-1235.

What is the market capitalization of the company?

The market capitalization is ₹1,065.06 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 21.71.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Kwality Pharmaceuticals Limited (ISIN: INE552U01010) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹1,065.06 crores and an average daily volume of 11,329 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.